Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced that its Biologics License Application (BLA) for imlifidase has been accepted by the U.S. Food and Drug ...

Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced that its Biologics License Application (BLA) for imlifidase ...

DOMs mean progress but you don't need to suffer in the aftermath of working out. Upping your potassium intake will ease cramps and restore fluids so you can rejoice in peaceful recovery ...

Diabetes and kidney disease are major risk factors for heart disease, yet many cases are undiagnosed. In addition, a consumer survey done last fall suggests that most people don't realize that their ...

By Juliet Aguiar DUGBARTEY, Agona NkwantaGhana Rubber Estates Limited (GREL) has donated a state-of-the-art chemistry ...

Atrasentan shows clinically meaningful effects on kidney function in IgA nephropathy patients, including those receiving SGLT2 inhibitors.

Hyperuricemia (HUA) is a metabolic disease caused by purine metabolism disorder, which is an important hub for many chronic ...

Drinking water in the morning can help improve alertness and weight management, as well as heart, metabolic, kidney, and skin ...

In an interview, Jackson Peter Kim, MD, clinical assistant professor in the Division of Nephrology at Stanford Health Care, ...

While proven to help, primary care clinicians have been slow to use the drugs once considered only for patients with diabetes ...

A total of 340 biopsy-confirmed IgAN patients were randomised to daily oral Vanrafia or a placebo for approximately 132 weeks.

Researchers in the United Kingdom have discovered that a simple combination of two common blood tests can help identify a serious and often overlooked complication of chronic kidney disease. The ...